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In a previous exploratory study we observed no relevant differences in psychopathology, 
personality, and functioning between inpatients diagnosed with gastrointestinal motor 
disorders (GMDs) or functional gastrointestinal disorders (FGDs) [1]. However, we 
observed higher levels of incongruence between clinician-assessed performance status and 
patients’ self-reported levels of functioning among patients diagnosed with FGDs. 
Likewise, research in other medical conditions has shown incongruences between self-
reported and clinician-reported or objective measures [2]. Furthermore, in a study on 
chronic depression, the authors found that discrepancies between patients’ and physicians’ 
assessments of medical comorbidities were related to higher levels of depressive 
symptomatology [3]. In this line, the aim of this study was to explore whether the 
inconsistencies between clinician-assessed and patient self-reported levels of functioning 
could be related to psychopathology among patients admitted for evaluation of 
gastrointestinal motility. 
Patients with chronic, severe and unexplained gastrointestinal symptoms admitted to a 
highly specialised digestive unit of a public university hospital, were included in the study 
after exclusion of organic lesions and mechanical obstruction by a thorough work-up. The 
protocol of the study had been approved by the Institutional Ethics Committee and all 
participants gave their written informed consent. 
All patients underwent body mass index (BMI) measurement, evaluation of small bowel 
motility by manometry, Rome III criteria, and psychiatric assessment. Patients with 
suspected gastroparesis underwent a scintigraphic gastric emptying test. The Karnofsky 
Performance Status, KPS [4], was used by gastroenterologists to assess levels of 
functioning. This clinician-administered scale covers a range running from 0 (death) to 100 
(full level of functioning). 
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In the first 72 hours after hospital admission, psychiatric assessment covering main 
psychopathological domains according to DSM-IV-TR [5] was performed, and a battery of 
psychometric tests was administered. The battery of self-administered questionnaires 
included perceived levels of functioning (assessed with the Short Form Health Survey, SF-
36 [6]) and psychopathology (using the multidimensional Revised version of the Symptom 
Checklist, SCL-90R [7]). 
During the study period, one hundred nineteen patients were enrolled. Eight patients were 
excluded after assessment, as they did not meet criteria for GMDs or FGDs. Among the one 
hundred eleven patients included, eight were not able to fill the psychometric tests given 
their delicate medical situation, and were also excluded from the study. 
According to the manometric assessment, twenty-one patients fulfilled criteria for intestinal 
dysmotility. They presented either a) relapsing acute episodes of intestinal pseudo-
obstruction with radiological evidence of intestinal air fluid levels interspersed with 
relatively symptom-free intervals (n=15), or b) chronic (>6 months) postprandial symptoms 
such as nausea, vomiting, poorly satiation, postprandial fullness,  abdominal 
discomfort/pain or distension (n=6), with reduced feeding tolerance and inability to 
maintain normal body weight, i.e. Body Mass Index (BMI) below 18.7 in women and 20.1 
in men. Among these patients, 12 fulfilled criteria for Irritable Bowel Syndrome (IBS) as a 
secondary diagnosis. The latter exhibited acute episodes of intestinal pseudoobstruction 
without symptoms in between. 
Twenty-nine patients presented clinical features compatible with gastroparesis (3 of them 
had also fulfilled criteria for intestinal dysmotility). These patients presented early satiation, 
postprandial fullness, epigastric discomfort/pain and all fulfilled Rome III criteria for 
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functional dyspepsia. In all of them gastroparesis was ruled out by evaluation of gastric 
motor function (scintigraphic gastric emptying test). Finally, twenty-two of them received 
a primary diagnosis of functional dyspepsia and 7 of gastroparesis. From the 56 remaining 
patients, 39 presented recurrent abdominal pain or discomfort with constipation, diarrhoea 
or both, fulfilling Rome III criteria for IBS. The remaining seventeen presented persistent 
or recurrent regurgitation of recently ingested food into the mouth, fulfilling criteria for 
Rumination Syndrome. Finally, 25 patients were primarily diagnosed with GMDs 
(Dysmotility=18, Gastroparesis=7) and 78 with FGDs (Dyspepsia=22, IBS=39, 
Rumination=17). 
For this study we defined incongruence as the difference between KPS and the SF-36 
physical functioning subscale scores (both ranging 0-100). Scores close to 0 would mean 
absolute congruence between clinician’s and patient’s perception of functioning; negative 
scores, higher perception of the patient; and positive, the opposite. 
SCL-90R scores were on average half standard deviation above the local population mean. 
As in our pilot study [1], differences between GMDs and FGDs in SCL-90R scores, 
duration of illness and BMI, did not yield statistical significant differences. However, we 
found a statistically significant difference in KPS scores (GMDs: 66±18 vs. FGDs: 75±13; 
t=2.9, p<.005). Spearman’s Rho correlations between the SCL-90 subscales and 
incongruence (table 1), were statistically significant for age and all psychopathological 
measures, with effect sizes ranging from .2 to .4. When these correlations were stratified by 
diagnostic group, we found that only somatization remained statistically significant in the 
case of GMDs (but did not remain statistically significant when we excluded the “nausea 
or upset stomach” item), while all variables except age remained statistically significant for 
FGDs with increased effect sizes for all SCL-90 subscales except somatisation (whose 
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effect size increased slightly when excluding nausea). Analyses of covariance (IV: 
diagnostic group, DV: psychopathology dimensions, Covariate: incongruence) showed no 
statistically significant differences in psychopathology levels between gastroenterological 
diagnostic groups when controlling for incongruence. We conducted an exploration of 
physical comorbidities among patients showing both high incongruence and somatization, 
finding severe illnesses in the GMDs group (including diabetes mellitus, lung 
transplantation, mitochondrial neurogastrointestinal encephalopathy disease, and cirrhosis), 
while the FGDs group showed less severe disorders such as fibromyalgia and pelvic 
inflammatory disease. 
Table 1. Correlation of the incongruence index with psychopathology 
 
 Total GMD FGD 
SCL90-R    
    
Somatization .404*** .394* .380*** 
Somatization excluding digestive item‡ .411*** .361 .400*** 
Obsessive-compulsive .351*** .259 .383*** 
Interpersonal  sensitivity .287** .069 .393*** 
Anxiety  .216* .206 .272* 
Depression .318** .249 .423*** 
Hostility .207* .003 .282* 
Phobic anxiety  .260** -.113 .407*** 
Psychoticism .300** .104 .401*** 
Paranoid ideation .271** .050 .361*** 
    
Incongruence: difference between KPS and the SF-36 physical functioning subscale scores (both with a 
range of 0-100). Scores close to 0 mean absolute congruence between clinician’s and patient’s perception of 
functioning; negative scores, higher perception of the patient; and positive, the opposite. 
GMD: Gastrointestinal Motor Disorders, FGD: Functional Gastrointestinal Disorders 
‡ Excluding item 40: “nausea or upset stomach”, * p<.05, ** p<.01, *** p<.001 
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This is the first study showing how the incongruence between clinician-assessed and patient 
self-reported levels of functioning is related to higher psychopathology among patients 
admitted for evaluation of gastrointestinal motor function. As it could be seen, somatization 
showed statistically significant correlations with incongruence in both diagnostic groups 
(this interaction seems to be related to severe medical conditions just in the GMDs group), 
while the remaining psychopathological domains correlated with incongruence to a greater 
extent in the FGDs group. 
Psychopathology seems to co-occur with a different view of functioning by clinicians and 
patients. Relatedly, it has been reported that gastroenterologists tend to misattribute FGDs 
diagnoses among patients with psychopathology, highlighting a need for improved 
psychosocial assessment in gastroenterological practice [8]. The concept of illness 
behaviour may help to understand the complex interactions that patients and doctors have 
in relation to gastrointestinal disorders, helping practitioners to develop an integrated vision 
of these patients [9]. 
This study had several limitations related to its design and methods. The research was 
conducted in a tertiary care setting, including exclusively inpatients, currently suffering 
from severe gastrointestinal symptoms. The instruments used in this study are not specially 
adapted to the characteristics of digestive patients. However, the use of universal 
instruments, like the SCL-90, SF-36 or KPS, allowed us to compare different types of 
digestive patients with a highly different range of symptoms. Furthermore, the nature of the 
SCL-90 scale doesn’t allow us to deepen in theoretical explanations about the origin of 
somatizations or its differentiation from physical comorbidities. Future research with more 
accurate and specific tools is needed.  The Diagnostic Criteria for Psychosomatic Research 
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(DCPR), could be a way of improving psychosomatic and psychosocial evaluation in 
medical settings [10]. 
In this study we have seen how the presence of incongruence between patients’ and 
clinician-provided levels of functioning could be a better proxy for psychopathology than 
having received a functional or a motor gastrointestinal disorder diagnosis. These results 
highlight the importance of considering the contrasts between subjective and clinical 
evaluations in digestive patients. 
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